Aimmune Therapeutics, Inc. Share Holder Equity 2015-2020 | AIMT
Aimmune Therapeutics, Inc. share holder equity from 2015 to 2020. Share holder equity can be defined as the sum of preferred and common equity items
| Aimmune Therapeutics, Inc. Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2019 | $104 |
| 2018 | $299 |
| 2017 | $178 |
| 2016 | $286 |
| 2015 | $206 |
| 2014 | $1 |
| 2013 | $12 |
| Aimmune Therapeutics, Inc. Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2020-06-30 | $180 |
| 2020-03-31 | $235 |
| 2019-12-31 | $104 |
| 2019-09-30 | $153 |
| 2019-06-30 | $205 |
| 2019-03-31 | $256 |
| 2018-12-31 | $299 |
| 2018-09-30 | $247 |
| 2018-06-30 | $288 |
| 2018-03-31 | $329 |
| 2017-12-31 | $178 |
| 2017-09-30 | $211 |
| 2017-06-30 | $237 |
| 2017-03-31 | $265 |
| 2016-12-31 | $286 |
| 2016-09-30 | $160 |
| 2016-06-30 | $179 |
| 2016-03-31 | $193 |
| 2015-12-31 | $206 |
| 2015-09-30 | $219 |
| 2015-06-30 | $58 |
| 2015-03-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
